| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4f3e04b44f258c7f603dd71afae13447
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_efce5f25e4bf569d11c0f2e7a6ba2eb2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_202236a21cc868159a15abd61e9de67f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T428-2982 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-001
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1647
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0024 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K2-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 |
| filingDate |
2012-02-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ef8fb59403bd08d92760cb55431cfe9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_495e57a8f610acd7f87eff171d51a102 |
| publicationDate |
2012-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2012164229-A1 |
| titleOfInvention |
Depot systems comprising glatiramer or pharmacologically acceptable salt thereof |
| abstract |
The present invention provides long acting parenteral pharmaceutical compositions comprising a therapeutically effective amount of glatiramer. In particular, the present invention provides a long acting pharmaceutical composition comprising a therapeutically effective amount of glatiramer acetate in depot form suitable for administering at a medically acceptable location in a subject in need thereof. The depot form is suitable for subcutaneous or intramuscular implantation or injection. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11510946-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3624815-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11167003-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8796226-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110709091-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9200114-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11413311-B2 |
| priorityDate |
2010-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |